FIGURE 1.
Schedule of split‐face exploratory treatments and assessments from baseline screening and randomization of candidate women and first treatment session (T0) up to the last assessment visit after six months (T3)
Schedule of split‐face exploratory treatments and assessments from baseline screening and randomization of candidate women and first treatment session (T0) up to the last assessment visit after six months (T3)